Aristotle Atlantic Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Sell
1,714,346
-128,098
-7% -$2.04M 1.11% 31
2025
Q4
$29.9M Sell
1,842,444
-1,284,275
-41% -$21M 1.37% 22
2025
Q3
$46.8M Buy
3,126,719
+247,402
+9% +$3.01M 1.36% 20
2025
Q2
$33.5M Sell
2,879,317
-61,895
-2% -$562K 1.02% 29
2025
Q1
$21.9M Buy
2,941,212
+54,510
+2% +$419K 0.74% 41
2024
Q4
$17.3M Sell
2,886,702
-114,499
-4% -$631K 0.54% 51
2024
Q3
$15.4M Buy
3,001,201
+27,013
+0.9% +$118K 0.48% 51
2024
Q2
$10.8M Sell
2,974,188
-18,375
-0.6% -$58.3K 0.35% 61
2024
Q1
$9.61M Sell
2,992,563
-58,121
-2% -$225K 0.31% 64
2023
Q4
$14.9M Sell
3,050,684
-7,522
-0.2% -$34.3K 0.53% 54
2023
Q3
$16.7M Sell
3,058,206
-46,755
-2% -$309K 0.67% 51
2023
Q2
$20.8M Buy
3,104,961
+1,197,872
+63% +$8.91M 0.78% 44
2023
Q1
$16.8M Buy
1,907,089
+26,522
+1% +$234K 0.87% 42
2022
Q4
$14.4M Sell
1,880,567
-13,828
-0.7% -$108K 0.8% 44
2022
Q3
$13.5M Buy
1,894,395
+565,127
+43% +$5.32M 0.82% 42
2022
Q2
$10.8M Buy
1,329,268
+569,856
+75% +$5.01M 0.83% 35
2022
Q1
$10.5M Buy
759,412
+13,617
+2% +$214K 0.65% 38
2021
Q4
$20.9M Buy
745,795
+18,461
+3% +$566K 1.21% 28
2021
Q3
$24.7M Buy
727,334
+9,684
+1% +$350K 1.64% 22
2021
Q2
$29.3M Buy
717,650
+146,708
+26% +$5.7M 1.93% 18
2021
Q1
$23M Buy
570,942
+22,562
+4% +$1.22M 1.68% 23
2020
Q4
$32.4M Buy
548,380
+17,235
+3% +$889K 2.5% 10
2020
Q3
$25.8M Buy
531,145
+19,413
+4% +$816K 2.28% 15
2020
Q2
$24.8M Buy
511,732
+140,891
+38% +$5.14M 2.38% 12
2020
Q1
$10.3M Buy
370,841
+7,232
+2% +$202K 1.57% 26
2019
Q4
$10.9M Buy
363,609
+313,150
+621% +$8.99M 1.39% 28
2019
Q3
$1.56M Buy
+50,459
New +$2.06M 0.45% 46

Other funds holding ADPT